No abstract

No abstract

No abstract

âïëèâ áàêòåð³îâèä³ëåííÿ òà òþòþíîïàë³ííÿ íà ñòàí áðîíõ³àëüíî¿ ïðîõ³äíîñò³ ó õâîðèõ íà òóáåðêóëüîç (ÒÁ) ëåãåíü. Óñòàíîâëåíî, ùî ôóíêö³îíàëüí³ îçíàêè áðîíõîîáñòðóêòèâíîãî ñèíäðîìó (ÁÎÑ) ïðè òóáåðêóëüîç³ ëåãåíü çíàõîäÿòüñÿ â ïðÿì³é ³ ò³ñí³é çàëåaeíîñò³ â³ä àêòèâíîñò³ òóáåðêóëüîçíîãî ïðîöåñó, â³ðîã³äíîþ îçíàêîþ ÿêîãî º âèä³ëåííÿ çáóäíèêà òóáåðêóëüîçó ç õàðêîòèííÿì. Òþòþíîïàë³ííÿ ³ñòîòíî óñêëàäíþº ôóíêö³î-íàëüí³ ïðîÿâè ÁÎÑ ó õâîðèõ íà òóáåðêóëüîç ëåãåíü.

As of October 2012 84 countries had reported at least 1 case of extensively drug resistant tuberculosis (EDR TB). In November 2012, the WHO epidemiological surveillance stated: all new TB cases in the world are 3,7 % of multi-drug resistant tuberculosis (MDR TB); 60,0 % of MDR TB among the new cases of TB are documented in Brazil, China, India, and South Africa.